JP2021152047A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021152047A5 JP2021152047A5 JP2021100791A JP2021100791A JP2021152047A5 JP 2021152047 A5 JP2021152047 A5 JP 2021152047A5 JP 2021100791 A JP2021100791 A JP 2021100791A JP 2021100791 A JP2021100791 A JP 2021100791A JP 2021152047 A5 JP2021152047 A5 JP 2021152047A5
- Authority
- JP
- Japan
- Prior art keywords
- salt
- filter
- buffer
- brimonidine
- production method
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000003839 salts Chemical class 0.000 claims 13
- 239000011780 sodium chloride Substances 0.000 claims 13
- UIIMBOGNXHQVGW-UHFFFAOYSA-M buffer Substances [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims 12
- 238000004519 manufacturing process Methods 0.000 claims 12
- 230000001629 suppression Effects 0.000 claims 12
- 239000007788 liquid Substances 0.000 claims 10
- 229940093158 Polyhexanide Drugs 0.000 claims 8
- 229920002413 Polyhexanide Polymers 0.000 claims 8
- XYLJNLCSTIOKRM-UHFFFAOYSA-N Alphagan Chemical compound C1=CC2=NC=CN=C2C(Br)=C1NC1=NCCN1 XYLJNLCSTIOKRM-UHFFFAOYSA-N 0.000 claims 7
- 229960003679 brimonidine Drugs 0.000 claims 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims 6
- 239000007864 aqueous solution Substances 0.000 claims 5
- 238000001914 filtration Methods 0.000 claims 5
- 230000001954 sterilising Effects 0.000 claims 5
- 238000004659 sterilization and disinfection Methods 0.000 claims 5
- 239000004327 boric acid Substances 0.000 claims 4
- 239000003795 chemical substances by application Substances 0.000 claims 3
- KGBXLFKZBHKPEV-UHFFFAOYSA-N Boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 claims 2
- 229960001724 Brimonidine tartrate Drugs 0.000 claims 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 2
- 239000002033 PVDF binder Substances 0.000 claims 2
- 239000004695 Polyether sulfone Substances 0.000 claims 2
- 239000007983 Tris buffer Substances 0.000 claims 2
- 125000005619 boric acid group Chemical group 0.000 claims 2
- QZHBYNSSDLTCRG-WUUYCOTASA-N brimonidine tartrate Chemical compound [H+].[H+].[O-]C(=O)[C@@H](O)[C@H](O)C([O-])=O.C1=CC2=NC=CN=C2C(Br)=C1NC1=NCCN1 QZHBYNSSDLTCRG-WUUYCOTASA-N 0.000 claims 2
- 239000003889 eye drop Substances 0.000 claims 2
- 239000000463 material Substances 0.000 claims 2
- 239000008363 phosphate buffer Substances 0.000 claims 2
- 229920002496 poly(ether sulfone) Polymers 0.000 claims 2
- 229920002981 polyvinylidene fluoride Polymers 0.000 claims 2
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
Claims (24)
ブリモニジン及び/又はその塩と、With brimonidine and / or its salt,
緩衝剤と、With a buffer,
ポリヘキサニド及び/又はその塩とWith polyhexanide and / or its salt
を含有させる、ブリモニジン及び/又はその塩のフィルターへの吸着抑制方法。A method for suppressing the adsorption of brimonidine and / or a salt thereof on a filter.
前記工程で得られた水性液剤を、フィルターを用いたろ過滅菌工程に供する工程、A step of subjecting the aqueous liquid obtained in the above step to a filtration sterilization step using a filter,
を含む、水性液剤の製造方法。A method for producing an aqueous liquid preparation including.
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2021100791A JP7002692B2 (en) | 2020-11-18 | 2021-06-17 | Aqueous liquid |
JP2021212111A JP7447072B2 (en) | 2020-11-18 | 2021-12-27 | aqueous liquid |
JP2022160514A JP7269425B2 (en) | 2020-11-18 | 2022-10-04 | aqueous solution |
JP2024028248A JP2024052871A (en) | 2020-11-18 | 2024-02-28 | Water-based liquid |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020191883A JP6901619B2 (en) | 2019-09-30 | 2020-11-18 | Aqueous solution |
JP2021100791A JP7002692B2 (en) | 2020-11-18 | 2021-06-17 | Aqueous liquid |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020191883A Division JP6901619B2 (en) | 2019-09-30 | 2020-11-18 | Aqueous solution |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021212111A Division JP7447072B2 (en) | 2020-11-18 | 2021-12-27 | aqueous liquid |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2021152047A JP2021152047A (en) | 2021-09-30 |
JP2021152047A5 true JP2021152047A5 (en) | 2021-11-18 |
JP7002692B2 JP7002692B2 (en) | 2022-02-04 |
Family
ID=77887204
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021100791A Active JP7002692B2 (en) | 2020-11-18 | 2021-06-17 | Aqueous liquid |
JP2021212111A Active JP7447072B2 (en) | 2020-11-18 | 2021-12-27 | aqueous liquid |
JP2024028248A Pending JP2024052871A (en) | 2020-11-18 | 2024-02-28 | Water-based liquid |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021212111A Active JP7447072B2 (en) | 2020-11-18 | 2021-12-27 | aqueous liquid |
JP2024028248A Pending JP2024052871A (en) | 2020-11-18 | 2024-02-28 | Water-based liquid |
Country Status (1)
Country | Link |
---|---|
JP (3) | JP7002692B2 (en) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050026924A1 (en) | 2000-07-14 | 2005-02-03 | Allergan, Inc. | Compositions containing alpha-2-adrenergic agonist components |
JP2013523828A (en) | 2010-04-07 | 2013-06-17 | アラーガン インコーポレイテッド | Preservative combinations for ophthalmic compositions |
CA3047279A1 (en) | 2016-12-15 | 2018-06-21 | Harrow Health, Inc. | Pharmaceutical formulations for treating glaucoma and methods for fabricating and using thereof |
-
2021
- 2021-06-17 JP JP2021100791A patent/JP7002692B2/en active Active
- 2021-12-27 JP JP2021212111A patent/JP7447072B2/en active Active
-
2024
- 2024-02-28 JP JP2024028248A patent/JP2024052871A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2012092139A5 (en) | ||
JP2013518926A5 (en) | ||
JP2018104711A5 (en) | ||
HRP20170625T1 (en) | Process for manufacturing a pharmaceutical preparation containing glatiramer acetate | |
WO2014008400A3 (en) | Fill-finish process for peptide solutions | |
JP2016027060A5 (en) | ||
DE2243800B1 (en) | PROCESS FOR PRODUCING REDUCED ALCOHOL BEER | |
AT409081B (en) | STABLE, NASAL, ORAL OR SUBLINGUAL APPLICABLE PHARMACEUTICAL PREPARATION | |
JP2019104727A5 (en) | ||
JP2021152047A5 (en) | ||
JP2024040421A5 (en) | ||
JP2020193233A5 (en) | ||
DE2233798A1 (en) | REMOVAL OF SULFUR-CONTAINING COMPOUNDS FROM WINE WITH THE HELP OF ELECTRODIALYSIS | |
HRP20180178T1 (en) | Ketorolac compositions for corneal wound healing | |
JP2022036159A5 (en) | ||
KR101653883B1 (en) | Method for manufacturing salted cabbage using turmeric | |
RU2016102844A (en) | RUROURONIA DRUG TO CAUSE PAIN REDUCTION, METHOD FOR ITS OBTAINING AND METHOD FOR REDUCING AND / OR REDUCING VASCULAR PAIN WHICH CAN BE CAUSED BY ITS USE | |
JP2016515517A5 (en) | ||
JP6234413B2 (en) | Calcium-enriched soy sauce seasoning | |
RU2015155396A (en) | Amber purification method | |
RU2016130965A (en) | Antiseptic veterinary medicine | |
RU2016147400A (en) | A method of treating cataracts and eye drops for its implementation | |
JP2015015905A5 (en) | ||
CN112334013A (en) | Method for producing dry bulbs having excellent restorability and preservability, and dry bulbs produced by the method | |
RU2016103215A (en) | METHOD OF INDUSTRIAL PRODUCTION OF SEA WATER, WHOLE SUITABLE FOR FOOD APPLICATION |